Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.
about
Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity.HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development.Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors.Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosisPulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.CD4+ T cell-independent DNA vaccination against opportunistic infections.Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.Polytope vaccines for the codelivery of multiple CD8 T-cell epitopes.DNA vaccination.Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection.Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.Epidermal delivery of protein and DNA vaccines.Respiratory syncytial virus infection: from biology to therapy: a perspective.Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.Confronting the barriers to develop novel vaccines against brucellosis.Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.Induction of CD8+ T-lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus.Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population.Induction of in vivo resistance to Mycobacterium avium infection by intramuscular injection with DNA encoding interleukin-18.
P2860
Q27472866-48C90C49-6495-4F10-9E7F-C65CD0925F5EQ30381447-AED91D05-C867-4C3A-ACDF-FD82D7AABA33Q33940220-3D60C6AB-F23F-49FE-BCE3-9A865A96360BQ34008163-86540949-7A06-4AC2-A360-DD90C88F1A9BQ34033850-8F46D56F-E132-45A2-9E9A-13948BE532BEQ34147169-B125C243-6781-4EE2-9521-C08366AFF72AQ34335296-66D27B86-3D7D-4A74-B1E9-7EB984E15177Q34482074-56707C31-CA8C-4BA4-805D-9C327C6B1610Q35193438-FEE1A54C-FDB3-4C37-9661-1933A74635A6Q35581126-BA030B83-C292-4035-88DC-EF7FF33367C5Q35830974-601D93C2-DCEF-4EC4-A128-C0A4CFD3436CQ35946874-7AE1B2F5-A04D-4F63-BA25-620E5472F887Q36066251-D536B647-1FB2-4298-840E-0FD90B6D3C74Q36316708-676C98CF-E46C-4144-8E7D-A46A336B74A0Q36834294-4A77ECE6-E5E2-4FE1-AB0D-84E0890AF13FQ37590335-082EC833-B1DC-4E01-8854-B80EF6425D5DQ37932521-FD523383-1A32-4903-9B8B-179FBB78168FQ39205543-AAF39438-57BD-49A0-830E-0E899112E43DQ45733282-A8DF8936-4646-4147-976A-6FDBC44FA1D0Q47573209-791A92CD-6A72-41BC-8304-3541391DED13Q54015727-8B22D27F-2474-4D04-A4FE-D68349C2BC33
P2860
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.
@ast
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.
@en
type
label
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.
@ast
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.
@en
prefLabel
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.
@ast
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.
@en
P2093
P2860
P1476
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity
@en
P2093
A J Ramsay
A Suhrbier
I A Ramshaw
S A Thomson
P2860
P356
10.1111/J.1600-065X.1999.TB01341.X
P577
1999-10-01T00:00:00Z